SCF ENCYCLOPEDIA ENTRY

POSTPARTUM ENDOMETRITIS

SCF-RDOS Registry Code: SCF-RDOS-PPD-INF-001

Disease Type Classification: Postpartum Infectious Disorder → Uterine Microbial Invasion Syndrome → Postpartum Endometritis

Adaptive Module Activation:

• Universal Core Module
• Infectious Disease Expansion
• Reproductive System Disease Expansion
• Immunologic Recovery Expansion
• Microbiome Expansion
• Sepsis Expansion
• Critical Care Expansion

1. SCOPE & POSITIONING

Etiology / Classification

Postpartum Endometritis is an acute infectious-inflammatory disorder involving the endometrium and decidual tissues following childbirth. It is the most common postpartum infectious complication and is particularly associated with cesarean delivery, prolonged labor, prolonged rupture of membranes, retained placental tissue, and invasive obstetric procedures.

The disease is typically polymicrobial and involves ascending infection from vaginal and cervical microbial communities into the recently delivered uterus.

Common microbial contributors include:

• Anaerobic bacteria
• Streptococcal species
• Enterococcal species
• Gram-negative enteric organisms
• Mixed vaginal flora

Within the SCF framework, Postpartum Endometritis is classified as:

A postpartum reproductive-microbial invasion syndrome characterized by disruption of uterine barrier integrity, polymicrobial colonization of postpartum uterine tissues, inflammatory amplification, impaired tissue recovery, and risk of systemic infectious dissemination.

SCF Classification

SCF Disease Category: Reproductive Infectious Recovery Failure Syndrome

SCF Functional Class:

Maternal Uterine Immune-Microbial Dysregulation Disorder

SCF Fault Tier Classification

Clinical Significance

Postpartum Endometritis remains a significant cause of postpartum morbidity worldwide.

Potential complications include:

• Persistent uterine infection
• Pelvic abscess
• Parametritis
• Septic pelvic thrombophlebitis
• Peritonitis
• Bacteremia
• Sepsis
• Septic shock
• Infertility
• Maternal mortality

SCF Domain Alignment

Primary Domains:

• Reproductive
• Infectious
• Immunologic
• Microbiologic

Secondary Domains:

• Hematologic
• Vascular
• Metabolic
• Critical Care

2. ETIOPATHOGENIC CORE

Primary Cause

Postpartum Endometritis develops when microbial organisms gain access to postpartum uterine tissues through a compromised reproductive tract environment created by delivery-related tissue disruption.

The disease reflects failure of:

• Uterine barrier restoration
• Local immune containment
• Microbial clearance mechanisms
• Tissue repair systems

Key Drivers

Driver A — Uterine Tissue Exposure

Following placental separation:

• Large endometrial wound surface develops
• Decidual tissues remain exposed

Result:

• Increased infection susceptibility

Driver B — Ascending Microbial Invasion

Microorganisms ascend from:

• Vagina
• Cervix
• Lower genital tract

Result:

• Uterine colonization

Driver C — Polymicrobial Bioactivity

Mixed bacterial populations produce:

• Tissue injury
• Toxin production
• Inflammatory activation

Result:

• Endometrial destruction

Driver D — Immune Dysregulation

Postpartum immune adaptation may impair:

• Local microbial clearance
• Effective inflammatory resolution

Result:

• Persistent infection

Driver E — Dissemination Potential

Untreated infection may spread to:

• Myometrium
• Parametrium
• Pelvis
• Bloodstream

Result:

• Sepsis risk

3. SCF FAULT ARCHITECTURE

4. PATHOGENESIS FLOW (SCF LOGIC)

Childbirth

↓

Placental Separation

↓

Endometrial Wound Formation

↓

Barrier Disruption

↓

Ascending Microbial Entry

↓

Endometrial Colonization

↓

Innate Immune Activation

↓

Inflammatory Cytokine Release

↓

Endometrial Infection

↓

Uterine Tenderness + Fever

↓

Postpartum Endometritis

↓

Pelvic Dissemination

↓

Sepsis (Severe Cases)

5. CLINICAL SPECTRUM

6. SCF TRINITY FRAMEWORK MAPPING

Trinity Axis I — Structural Integrity

Affected Systems:

• Endometrium
• Decidua
• Myometrium
• Uterine vasculature

Primary Failure:

• Postpartum uterine barrier disruption

Trinity Axis II — Energetic Integrity

Affected Systems:

• Cellular repair systems
• Mitochondrial immune metabolism
• Tissue regeneration pathways

Primary Failure:

• Infection-driven repair suppression

Trinity Axis III — Informational Integrity

Affected Systems:

• Innate immune signaling
• Microbiome-host communication
• Inflammatory regulation networks

Primary Failure:

• Failed microbial containment signaling

7. ENDOMETRITIS EXPANSION MODULE

Clinical Subtype Registry

Type A

Classic Postpartum Endometritis

Characteristics:

• Most common presentation
• Fever and uterine tenderness

Type B

Cesarean-Associated Endometritis

Characteristics:

• Higher bacterial burden
• Increased complication risk

Type C

Retained Tissue-Associated Endometritis

Characteristics:

• Persistent infection source
• Delayed resolution

Type D

Anaerobic-Dominant Endometritis

Characteristics:

• Foul-smelling lochia
• Extensive tissue inflammation

Type E

Septic Endometritis

Characteristics:

• Bacteremia
• Sepsis
• Organ dysfunction

8. MULTI-OMICS PATHOGENESIS MAP

9. SCF PCR THERAPEUTIC STRATEGY

PREVENTATIVE

Objectives

Prevent postpartum uterine infection.

Targets:

• Surgical prophylaxis
• Infection-risk reduction
• Microbial containment
• Tissue healing optimization

CURATIVE

Objectives

Eradicate infection and prevent dissemination.

Targets:

• Bacterial burden
• Inflammatory injury
• Uterine tissue damage
• Systemic spread

Interventions:

• Broad-spectrum antimicrobial therapy
• Source control
• Supportive care
• Monitoring for complications

RESTORATIVE

Objectives

Restore uterine integrity and reproductive resilience.

Targets:

• Endometrial healing
• Microbiome normalization
• Immune recovery
• Reproductive function preservation

Potential strategies:

• SCF-derived reproductive tissue restoration platforms
• Precision microbiome recovery systems
• Anti-inflammatory regenerative therapeutics
• Reproductive resilience optimization programs

10. CURRENT STANDARD OF CARE

Diagnostic Evaluation

Clinical Assessment

Core findings:

• Fever
• Uterine tenderness
• Lower abdominal pain
• Foul-smelling lochia
• Tachycardia

Laboratory Evaluation

• Complete blood count
• Blood cultures when indicated
• Inflammatory markers
• Lactate in severe disease

Imaging

When indicated:

• Pelvic ultrasound
• CT imaging
• MRI

Used to evaluate:

• Retained products of conception
• Pelvic abscess
• Alternative diagnoses

Treatment

Antimicrobial Therapy

Prompt administration of broad-spectrum antibiotics remains the cornerstone of treatment.

Source Control

When indicated:

• Removal of retained tissue
• Drainage of abscesses

Critical Care Support

For severe disease:

• Hemodynamic monitoring
• Sepsis management
• Organ support

11. SCF THERAPEUTIC ENGINEERING OPPORTUNITIES

SCF Target Cluster A

Uterine Barrier Restoration Platform

Targets:

• Endometrial healing
• Tissue regeneration
• Barrier integrity restoration

SCF Target Cluster B

Precision Antimicrobial Platform

Targets:

• Polymicrobial infections
• Biofilm disruption
• Resistance prevention

SCF Target Cluster C

Immunologic Recovery Platform

Targets:

• Balanced inflammatory resolution
• Immune restoration
• Tissue preservation

SCF Target Cluster D

Reproductive Resilience Platform

Targets:

• Fertility preservation
• Endometrial recovery
• Long-term reproductive health

12. TRANSLATIONAL BLUEPRINT

Diagnostic Biomarkers

Infection

• Procalcitonin
• CRP
• White blood cell count

Inflammatory

• IL-6
• TNF-α
• Neutrophil activation markers

Tissue Injury

• Endometrial inflammatory biomarkers
• Matrix remodeling markers

Sepsis Monitoring

• Lactate
• Organ dysfunction biomarkers

Clinical Endpoints

Primary:

• Resolution of infection

Secondary:

• Fever resolution
• Prevention of sepsis
• Preservation of reproductive function
• Reduction of hospitalization duration

FDA Translational Pathway

Preclinical

↓

IND

↓

Phase I Safety

↓

Phase II Anti-Infective Efficacy Studies

↓

Phase III Maternal Infection Resolution Trials

↓

NDA/BLA Submission

13. SCF DBI INTERPRETATION

Decentralized Biological Intelligence Failure

Cellular Layer

Immune cells fail to rapidly eliminate invading microorganisms from exposed postpartum uterine tissues.

Tissue Layer

The endometrium becomes a site of sustained microbial colonization and inflammatory injury.

Organ Layer

The uterus loses its ability to maintain sterile recovery following childbirth.

System Layer

Immune, reproductive, inflammatory, and microbial control systems become overwhelmed by progressive infection.

Whole-Organism Layer

The maternal recovery process is interrupted by microbial invasion of vulnerable postpartum uterine tissues, transforming physiologic healing into a potentially systemic infectious disease process.

14. SCF LAYMAN’S SUMMARY

Postpartum Endometritis is an infection of the lining of the uterus that develops after childbirth.

According to the SCF model, delivery leaves a temporary wound inside the uterus where the placenta was attached. If bacteria enter this area before healing is complete, an infection can develop and spread through the uterine tissues.

Common symptoms include:

• Fever
• Lower abdominal pain
• Uterine tenderness
• Chills
• Fatigue
• Foul-smelling vaginal discharge

Most women recover completely with prompt antibiotic treatment. However, if the infection is not recognized early, it can spread into the pelvis or bloodstream and become life-threatening.

SCF-RDOS INDICATION SUMMARY